Stay updated on Adjuvant Pembrolizumab in Esophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the Adjuvant Pembrolizumab in Esophageal Cancer Clinical Trial page.

Latest updates to the Adjuvant Pembrolizumab in Esophageal Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedNew Revision: v3.5.4 appears on the page, replacing the old v3.5.3 tag. This is a minor metadata update to the page, not altering the study content or results.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check38 days agoChange DetectedUpdated the site’s displayed release/revision version from **v3.5.2** to **v3.5.3** at the bottom of the page.SummaryDifference0.1%

- Check45 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision: v3.5.0 was added and v3.4.3 was removed. This update reflects backend versioning and does not change visible content or functionality.SummaryDifference0.1%

- Check88 days agoChange DetectedStudy status updated to Completed, replacing the previous Active, not recruiting status.SummaryDifference0.4%

- Check110 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Adjuvant Pembrolizumab in Esophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjuvant Pembrolizumab in Esophageal Cancer Clinical Trial page.